Correspondence 0001193125-23-243840 from Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171) (RVMD)
Revolution Medicines, Inc. (RVMD, RVMDW) (CIK 0001628171)
Date: Sept. 27, 2023 · CIK: 0001628171 · Accession: 0001193125-23-243840
AI Filing Summary & Sentiment
File numbers found in text: 333-274499
Letter
Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City, California 94063
September 27, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Re: Revolution Medicines, Inc.
Registration Statement on Form S-4
File No. 333-274499
Request for Acceleration of Effectiveness
To the addressee set forth above:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Revolution Medicines, Inc. (the “Registrant”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-274499), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Time on September 29, 2023, or as soon as possible thereafter. The Registrant hereby authorizes Mark V. Roeder, Joshua M. Dubofsky, Ian Nussbaum or John C. Williams, of Latham & Watkins LLP, to orally modify or withdraw this request for acceleration.
We request that we be notified of such effectiveness by a telephone call to Mr. Williams at (415) 395-8223 or, in his absence, Mr. Roeder, of Latham & Watkins LLP, at (650) 463-3043. Thank you for your assistance.
Very truly yours,
Revolution Medicines, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Revolution Medicines, Inc. 700 Saginaw Drive Redwood City, California 94063 September 27, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Revolution Medicines, Inc. Registration Statement on Form S-4 File No. 333-274499 Request for Acceleration of Effectiveness To the addressee set forth above: In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Revolution Medicines, Inc. (the “Registrant”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-274499), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Time on September 29, 2023, or as soon as possible thereafter. The Registrant hereby authorizes Mark V. Roeder, Joshua M. Dubofsky, Ian Nussbaum or John C. Williams, of Latham & Watkins LLP, to orally modify or withdraw this request for acceleration. We request that we be notified of such effectiveness by a telephone call to Mr. Williams at (415) 395-8223 or, in his absence, Mr. Roeder, of Latham & Watkins LLP, at (650) 463-3043. Thank you for your assistance. Very truly yours, Revolution Medicines, Inc. /s/ Jeff Cislini Jeff Cislini General Counsel cc: Mark A. Goldsmith, Revolution Medicines, Inc. John C. Williams, Latham & Watkins LLP Mark V. Roeder, Latham & Watkins LLP